L162-0110 Screening compound: 1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide

L162-0110 Screening compound: 1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide
L162-0110 Screening compound: 1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L162-0110
1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L162-0110

Molecular Formula

C29H37N5O2 (C29 H37 N5 O2)

Compound Name

1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide

IUPAC name

1-[4-(4-methoxyphenyl)piperazin-1-yl]-N-[2-(2-methylpiperidin-1-yl)ethyl]isoquinoline-7-carboxamide

SMILES

CC1N(CCNC(c2cc3c(N(CC4)CCN4c(cc4)ccc4OC)nccc3cc2)=O)CCCC1

InChI

InChI=1S/C29H37N5O2/c1-22-5-3-4-15-32(22)16-14-31-29(35)24-7-6-23-12-13-30-28(27(23)21-24)34-19-17-33(18-20-34)25-8-10-26(36-2)11-9-25/h6-13,21-22H,3-5,14-20H2,1-2H3,(H,31,35)/t22-/m0/s1

InChI Key

NUHZXHPBALISQF-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD27235174

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

487.65

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.271

Distribution Coefficient, logD

3.038

Water Solubility, LogSw

-4.21

Polar Surface Area

50.892

Acid Dissociation Constant (pKa)

12.29

Base Dissociation Constant (pKb)

8.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.80

L162-0110 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Protein-Protein Interaction Library (218420 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with L162-0110 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L162-0110?
Check Price and Availability of L162-0110, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L162-0110 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L162-0110
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L162-0110
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L162-0110 available by request